Verition Fund Management LLC Avadel Pharmaceuticals PLC Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Verition Fund Management LLC holds 141,600 shares of AVDL stock, worth $1.19 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
141,600Holding current value
$1.19 Million% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AVDL
# of Institutions
6Shares Held
738KCall Options Held
0Put Options Held
0-
Knoll Capital Management, LLC Miami, FL600KShares$5.05 Million4.07% of portfolio
-
Schulhoff & CO Inc137KShares$1.15 Million0.67% of portfolio
-
American Portfolios Advisors Holbrook, NY500Shares$4,2050.0% of portfolio
-
American Research & Management Co.100Shares$8410.0% of portfolio
-
Exane Derivatives33Shares$2770.0% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $509M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...